IDOX PLC
03 August 2006
IDOX PLC
3 August 2006
For immediate release
3 August 2006
IDOX plc ('IDOX' or 'the Company')
Director Shareholding
The Board of IDOX announces that John Wisbey, Non-Executive Director, acquired,
on 2 August 2006, 100,000 ordinary shares in the Company at an average price of
6.50p per share. John Wisbey is now interested in a personal capacity in 405,000
ordinary shares in IDOX representing 0.21% of the current issued share capital.
John Wisbey also holds interests in IDOX through the shareholdings of Advanced
Technology Trust and Lombard Risk Management plc ('LRM') which hold respectively
11,266,666 and 5,601,546 shares. John Wisbey is a beneficiary of Advanced
Technology Trust and a director and significant shareholder of LRM. The total
beneficial interest of John Wisbey in IDOX has now increased to 17,273,212
ordinary shares representing 8.85% of the current issued share capital of the
Company.
The ordinary shares referred to above are the ordinary shares of 1p per share.
For further information please contact:
Martin Brooks, Chairman and CEO, IDOX plc 0870 333 7101
John McNicol, Company Secretary, IDOX plc 0141 574 1935
Matthew Hall, Noble & Company Limited 020 7763 2200
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.